Cytosorbents shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and announced a price target of $10.
Portfolio Pulse from Benzinga Newsdesk
Cytosorbents shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and announced a price target of $10.
July 29, 2024 | 4:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cytosorbents shares are trading higher following EF Hutton's initiation of coverage with a Buy rating and a $10 price target.
The initiation of coverage with a Buy rating and a specific price target of $10 by a reputable firm like EF Hutton is likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100